We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Transplanting animal organs into humans is an attractive approach, but the risk of immune rejection or catching a virus from the organ has been a significant roadblock. eGenesis used CRISPR to address the latter concern.